> 18/01/10 Phoenix Eagle commences clinical trial. > 01/12/09 OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.
Phoenix Eagle wishes to thank the following companies for their valuable contribution to its development.